These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 26916953)

  • 41. GATA3 expression in sarcomatoid urothelial carcinoma of the bladder.
    Fatima N; Osunkoya AO
    Hum Pathol; 2014 Aug; 45(8):1625-9. PubMed ID: 24824028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder.
    Li B; Kanamaru H; Noriki S; Yamaguchi T; Fukuda M; Okada K
    Urol Res; 1998; 26(4):235-41. PubMed ID: 9759996
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibroblast growth factor receptor 3 activation plays a causative role in urothelial cancer pathogenesis in cooperation with Pten loss in mice.
    Foth M; Ahmad I; van Rhijn BW; van der Kwast T; Bergman AM; King L; Ridgway R; Leung HY; Fraser S; Sansom OJ; Iwata T
    J Pathol; 2014 Jun; 233(2):148-58. PubMed ID: 24519156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protein networking in bladder cancer: immunoreactivity for FGFR3, EGFR, ERBB2, KAI1, PTEN, and RAS in normal and malignant urothelium.
    Røtterud R; Fosså SD; Nesland JM
    Histol Histopathol; 2007 Apr; 22(4):349-63. PubMed ID: 17290345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.
    DeGraff DJ; Clark PE; Cates JM; Yamashita H; Robinson VL; Yu X; Smolkin ME; Chang SS; Cookson MS; Herrick MK; Shariat SF; Steinberg GD; Frierson HF; Wu XR; Theodorescu D; Matusik RJ
    PLoS One; 2012; 7(5):e36669. PubMed ID: 22590586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prognostic significance of nuclear CSE1L in urinary bladder urothelial carcinomas.
    Chang CC; Tai CJ; Su TC; Shen KH; Lin SH; Yeh CM; Yeh KT; Lin YM; Jiang MC
    Ann Diagn Pathol; 2012 Oct; 16(5):362-8. PubMed ID: 22476051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential expression of GATA-3 in urothelial carcinoma variants.
    Liang Y; Heitzman J; Kamat AM; Dinney CP; Czerniak B; Guo CC
    Hum Pathol; 2014 Jul; 45(7):1466-72. PubMed ID: 24745616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.
    Moll R; Achtstätter T; Becht E; Balcarova-Ständer J; Ittensohn M; Franke WW
    Am J Pathol; 1988 Jul; 132(1):123-44. PubMed ID: 2456018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
    APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants.
    Perez-Montiel D; Wakely PE; Hes O; Michal M; Suster S
    Mod Pathol; 2006 Apr; 19(4):494-503. PubMed ID: 16474378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The expression of beta human chorionic gonadotrophin (β-HCG) in human urothelial carcinoma.
    Venyo AK; Herring D; Greenwood H; Maloney DJ
    Pan Afr Med J; 2010; 7():20. PubMed ID: 21918707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a tissue microarray study of 112 cases.
    Chaux A; Munari E; Cubilla AL; Hicks J; Lecksell K; Burnett AL; Netto GJ
    Histopathology; 2014 May; 64(6):863-71. PubMed ID: 24279699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nested and microcystic variants of urothelial carcinoma displaying immunohistochemical features of basal-like urothelial cells: an immunohistochemical and histopathogenetic study.
    Mai KT; Hakim SW; Ball CG; Flood TA; Belanger EC
    Pathol Int; 2014 Aug; 64(8):375-81. PubMed ID: 25143125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microcystic urothelial carcinoma: morphology, immunohistochemistry and clinical behaviour.
    Lopez Beltran A; Montironi R; Cheng L
    Histopathology; 2014 May; 64(6):872-9. PubMed ID: 24321001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression.
    Hagikura M; Murakumo Y; Hasegawa M; Jijiwa M; Hagiwara S; Mii S; Hagikura S; Matsukawa Y; Yoshino Y; Hattori R; Wakai K; Nakamura S; Gotoh M; Takahashi M
    Pathol Int; 2010 Nov; 60(11):735-43. PubMed ID: 20946523
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased DNA methyltransferase 1 protein expression in human transitional cell carcinoma of the bladder.
    Nakagawa T; Kanai Y; Saito Y; Kitamura T; Kakizoe T; Hirohashi S
    J Urol; 2003 Dec; 170(6 Pt 1):2463-6. PubMed ID: 14634451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistochemical determination of ETS-1 oncoprotein expression in urothelial carcinomas of the urinary bladder.
    Sari A; Calli A; Gorgel SN; Altinboga AA; Kara C; Dincel C; Cakalagaoglu F
    Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):153-8. PubMed ID: 21623185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
    Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
    Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence of Bcl-2 expression in bladder cancer: relation to schistosomiasis.
    Swellam M; Abd-Elmaksoud N; Halim MH; Khatab H; Khiry H
    Clin Biochem; 2004 Sep; 37(9):798-802. PubMed ID: 15329319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.